Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Li-Di Xu

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Genes|December 27, 2018
ADAR1 Editing and its Role in CancerLi-Di Xu, Marie Öhman
Seminars in Cell & Developmental Biology|November 18, 2017
ADARs and editing: The role of A-to-I RNA modification in cancer progressionKajsa Fritzell, Li-Di Xu, Jens Lagergren, et al.
Research and Reports in Urology|May 19, 2022
A Novel Risk Score (P-score) Based on a Three-Gene Signature, for Estimating the Risk of Prostate Cancer-Specific MortalityFabian Söderdahl, Li-Di Xu, Johan Bring, et al.
Nucleic Acids Research|December 28, 2018
Sensitive ADAR editing reporter in cancer cells enables high-throughput screening of small molecule librariesKajsa Fritzell, Li-Di Xu, Magdalena Otrocka, et al.
The Prostate|March 29, 2023
Validation of the prognostic value of a three-gene signature and clinical parameters-based risk score in prostate cancer patientsArni Saemundsson, Li-Di Xu, Florian Meisgen, et al.
JMIR Research Protocols|September 20, 2023
Multidimensional Analysis of a Cell-Free DNA Whole Methylome Sequencing Assay for Early Detection of Gastric Cancer: Protocol for an Observational Case-Control StudyYongjun Han, Jiangpeng Wei, Weidong Wang, et al.
Oncotarget|December 18, 2015
Genome-wide identification of Wig-1 mRNA targets by RIP-Seq analysisCinzia Bersani, Mikael Huss, Stefania Giacomello, et al.
Plos One|November 8, 2014
Expression of the p53 target Wig-1 is associated with HPV status and patient survival in cervical carcinomaLi-Di Xu, Susanne Muller, Srinivasan R Thoppe, et al.
Molecular Cancer|May 1, 2025
Multi‑omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinomaBing Liu, Wei Tao, Xuantong Zhou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2025
Quantitative and Dynamic ctDNA as a Biomarker of Response and Survival in Patients With Advanced Lung Squamous Cell Carcinoma Receiving Immunochemotherapy or Chemotherapy AloneFei Zhou, Jiao Zhang, Shengxiang Ren, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Genes|December 27, 2018
ADAR1 Editing and its Role in CancerLi-Di Xu, Marie Öhman
Seminars in Cell & Developmental Biology|November 18, 2017
ADARs and editing: The role of A-to-I RNA modification in cancer progressionKajsa Fritzell, Li-Di Xu, Jens Lagergren, et al.
Research and Reports in Urology|May 19, 2022
A Novel Risk Score (P-score) Based on a Three-Gene Signature, for Estimating the Risk of Prostate Cancer-Specific MortalityFabian Söderdahl, Li-Di Xu, Johan Bring, et al.
Nucleic Acids Research|December 28, 2018
Sensitive ADAR editing reporter in cancer cells enables high-throughput screening of small molecule librariesKajsa Fritzell, Li-Di Xu, Magdalena Otrocka, et al.
The Prostate|March 29, 2023
Validation of the prognostic value of a three-gene signature and clinical parameters-based risk score in prostate cancer patientsArni Saemundsson, Li-Di Xu, Florian Meisgen, et al.
JMIR Research Protocols|September 20, 2023
Multidimensional Analysis of a Cell-Free DNA Whole Methylome Sequencing Assay for Early Detection of Gastric Cancer: Protocol for an Observational Case-Control StudyYongjun Han, Jiangpeng Wei, Weidong Wang, et al.
Oncotarget|December 18, 2015
Genome-wide identification of Wig-1 mRNA targets by RIP-Seq analysisCinzia Bersani, Mikael Huss, Stefania Giacomello, et al.
Plos One|November 8, 2014
Expression of the p53 target Wig-1 is associated with HPV status and patient survival in cervical carcinomaLi-Di Xu, Susanne Muller, Srinivasan R Thoppe, et al.
Molecular Cancer|May 1, 2025
Multi‑omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinomaBing Liu, Wei Tao, Xuantong Zhou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 5, 2025
Quantitative and Dynamic ctDNA as a Biomarker of Response and Survival in Patients With Advanced Lung Squamous Cell Carcinoma Receiving Immunochemotherapy or Chemotherapy AloneFei Zhou, Jiao Zhang, Shengxiang Ren, et al.
Pageof 2